HealthInvest Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

HealthInvest Partners’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-138,836	Closed	-$2.96M	–	46
2024 Q1	$2.96M	Buy	138,836 +13,836	+11%	+$165K	1.8%	22
2023 Q4	$1.2M	Buy	+125,000	New	+$607K	0.94%	27

HealthInvest Partners's FUSN Position: Q2 2024 in Review

HealthInvest Partners sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 138,836 shares — an estimated $2.96M sold.

HealthInvest Partners first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $2.96M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

HealthInvest Partners reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
HealthInvest Partners sold 138,836 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.96M.
HealthInvest Partners first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
HealthInvest Partners's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.96M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on HealthInvest Partners's 13F filing for Q2 2024, filed 14 Aug 2024.